Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지

Towards a Structure-Function Relationship for Vascular Endothelial Growth Factor-B (VEGF-B)

  • Scrofani, Sergio D.B. (AMRAD Operations Pty Ltd, Richmond, Australia) ;
  • Nash, Andrew D. (AMRAD Operations Pty Ltd, Richmond, Australia)
  • Published : 2001.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

The vascular endothelial growth factor (VEGF), or VEGF-A, is intimately involved in both physiological and pathological forms of angiogenesis. VEGF-A is now recognized as the founding member of a family of growth factors that has expanded to include VEGF-B, VEGF-C, VEGF-D, VEGF-E, and placental growth factor (PIGF). This family of cytokines binds differentially to at least three receptor tyrosine kinases, however, the extent to which family members other than VEGF-A contribute to physiological and pathological angiogenesis remains unclear. Issues that are of relevance include uncertainty regarding the consequences of signaling through VEGF - RI in particular, and the ability of some family members to heterodimerize, leading to the possibility ofheterodimeric receptor complexes. Structural characterization is one approach that can be used to address these issues, however, the vast majority of previous structure-function studies have only focused on VEGF-A. While these studies may provide some clues regarding the structural basis of the interaction of other family members with their receptors, studies using the ligands themselves are clearly required if highly specific interactions are to be revealed. With the recent progress toward refolding and purifying substantial' quantities of other VEGF family members, such structural studies are now possible. Here, these ~ssues are addressed with a particular emphasis on VEGF-B and its receptors.

Keywords

References

  1. Proc. Natl. Acad. Sci. v.95 Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) and VEGF receptor 3 (Flt4) Achen, M.;M. Jeltsch;E. Kukk;T. Makinen;A. Vitali;A. Wilks;K. Alitalo;S. Stacker
  2. J. Biol. Chem v.250 Nonenzymatic reactivation of reduced bovine pancreatic ribonuclease by air oxidation and by glutathione oxidoreduction buffers Ahmed, A.K.;S. W. Schaffer;D. B. Wetlaufer
  3. N. Engl. J. Med v.331 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders Aiello, L. P.;R. L. Avery;P. G. Arrigg;B. A. Keyt;H. D. Jampel;S. T. Shah;L. R. Pasquale;H. Thieme;M. A. Iwamoto;J. E. Park;H. V. Nguyen;L. M. Aiello;N. Ferrara;G. L. King
  4. J. Biol. Chem v.272 Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor Flt-1 Barleon, B.;F. Totzke;C. Hertzog;S. Blanke;E. Kremmer;G. Siemeister;D. Marme;G. Martiny-Baron
  5. J. Biol. Chem. v.275 VEGF activates signal transducers and activators of transcription proteins in aortic endothelial cells Bartoli, M.;X. Gu;N. T. Tsai;R. C. Venema;S. E. Brooks;M. B. Marrero;R. B. Caldwell
  6. Circ. Res. v.86 Mice lacking the vascular endothelial growth factor-B gene (VEGF-B) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia Bellomo. D.;J. P. Headrick;G. U. Silins;C. A. Paterson;P. Thomas;M. Gartside;A. Mould;M. M. Cahill;I. D. Tonks;S. M. Grimmond;S. Townson;C. Wells;M. Little;M. C. Cummings;N. K. Hayward;G. F. Kay
  7. Biochem. J. v.316 Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor Birkenhager, R.;B. Schneppe;W. Rockl;J. Wilting;H. A. Weich;J. E. McCarthy
  8. Biol. Chem. v.271 Heterodimers of placenta growth factor/vascular endothelial growth factor. Enothelial activity, tumor cell experessin, and high affinity binding to Flk-1/KDR. Cao, Y.;H. Chen;L. Zhou;M. K. Chiang;B. Anand-Apte;J. A. Weatherbee;Y. Wang;F. Fang;J. G. Flanagan;M. L. Tsang
  9. Biochem. Biophys. Res. Commun v.235 Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing Cao, Y.;W. R. Ji;P. Qi;A. Rosin
  10. Nature Med. v.6 Mechanisms of angiogenesis and arteriogenesis Carmeliet, P.
  11. Nature Med. v.5 Impaired mycardial angiogensis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Carmeliet, P.;Y. S. Ng;D. Nuyens;G. Theilmeier;K. Brusselmans;I. Comelissen;E. Ehler;V. Kakkar;I. Stalmans;V. Mattot;J. C. Perriard;M. Dewerchin;W. Flameng;A. Nagy;F. Lupu;L. Moons;D. Collen;P. A. D'Amore;D. T. Shima
  12. J. Biol. Chem. v.271 The vascular endothelial growth factor receptor Flt-1 mediates biological activities Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis Clauss, M.;H. Weich;G. Breier;U. Knies;W. Rockl;J. Waltenberger;W. Risau
  13. Ann. Rheum. Dis. v.51 Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implications Colville-Nash, P. R.;D. L. Scott
  14. Biochem. Biophys. Res. Commun v.231 Identification of the extracellular domains of Flt-1 that mediate ligand interactions Cunningham, S.A.;C.C. Stephan;M.P. Arrate;K.G. Ayer;T. A. Brock
  15. EMBO J. v.15 The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade Davis-Smyth, T.;H. Chen;J. Park;L. G. Presta;N. Ferrara
  16. Curr. Opin. Biotechnol v.9 Refolding of recombinant proteins De Bernardez Clark, E.
  17. Science v.262 Mutations that allow disulfide bond formation in the cytoplasm Escherichia coli. Derman, A.I.;W.A. Prinz;D. Belin;J. Beckwith
  18. Science v.255 The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor de Vries, C.;J.A. Escobedo;H. Ueno;K. Houck;F. Ferrara;L. T. Williams
  19. J. Biol. Chem v.270 Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer DiSalvo, J.;M. L. Bayne;G. Conn;P.W. Kwok;P. G. Trivedi;D.D. Soderman;T.M. Palisi;K.A. Sullivan;K. A. Thomas
  20. Protein Sci. v.10 $^1H,^13C,$ and $^15N$ backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor Fairbrother, W.J.;M.A. Champe;H.W. Christinger;B.A. Keyt;M.A. Starovasnik
  21. Structure v.6 Solution structure of the heparin-binding domain of vascular endothelial growth factor Fairbrother, W.J.;M. A. Champe;H. W. Christinger;B. A. Keyt;M.A. Starovasnik
  22. Kidney Int v.56 Role of vascular endothelial growth factor in the ergulation of angiogenesis Ferrara, N.
  23. Nature Med. v.5 Clinical applications of angiogenic growth factors and their inhibitors Ferrara, N.;K. Alitalo
  24. N. Engl. J. Med v.285 Tumor angiogensis: Therapeutic implications Folkmann, J.
  25. Nature v.376 Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium Fong, G.-H.;J. Rossant;M. Gertscnstcin;M. L. Beritman
  26. J. Biol. Chem. v.275 The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-1 Fuh, G.;K. C. Garcia;A. M. de Vos.
  27. J. Biol. Chem v.272 Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia Gerber, H. P.;F. Condorelli;J. Park;N. Ferrara
  28. EMBO J. v.19 A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factordependent phosphatidylinositol 3'-kinase activation and endothelial cell migration Gille, H.;J. Kowalski;L. Yu;H. Chen;M. T. Pisabarro;T. Davis-Smyth;N. Ferrara
  29. Genome Res. v.6 Cloning and characterisation of a novel human gene related to vascular endothelial growth factor Grimmond, S.;J. Lagercrantz;C. Drinkwater;G. Silins;S. Townson;P. Pollock;D. Gotley;E. Carson;S. Rakar;M. Nordenskjold;L. Ward;N. Hayward;G. Weber
  30. Science v.277 Signaling vascular morphogenesis and maintenance Hanahan, D.
  31. Proc. Natl. Acad. Sci. USA v.95 Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice Hiratsuka, S.;O. Minowa;J. Kuno;T. Noda;M. Shibuya
  32. Mol. Endocrinol v.5 The vascular endothelial growth factor family. Identification of a fouth molecular species and characterization of alternative splicing of RNA Houck, K.;N. Ferrara;J. Winer;G. Cachiames;B. Li;D.W. Leung
  33. Invest. Ophthalmol-1. Vis. Sci. v.41 Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy Ishida, S.;K. Shinoda;S.Kawashima;Y. Oguchi;Y. Oguchi;Y. Okada;E. Ikeda
  34. Proc. Natl. Acad. Sci. USA v.97 Vascular endothelial growth factor: Direct neuroprotective effect in vitro ischemia Jin, K. L.;X. O. Mao;D. A. Greenberg
  35. EMBO J. v.15 A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4(VEGFR-3)and KDR(VEGFR-2) receptor tyrosine kinases Joukov, V.;K. Pajusola;A. Kaipainen;D. Chilov;I. Lahtinen;E. Kukk;O. Saksela;N. Kalkkinen;K. Alitalo
  36. EMBO J. v.16 Proteolytic processing regulates receptor specificity and activity of VEGF-C Joukov, V.;T. Sarsa;V. Kumar;M. Jeltsch;L. Claesson-Welsh;Y. Cao;O. Saksela;N. Kalkkinen;K. Alitalo
  37. Arch. Biochem. Biophys v.344 Disulfide structure of the heparin binding domain in vascular endothelial growth factor: Characterization of posttranslational modifications i VEGF Keck, R. G.;L. Berleau;R. Harris;B. A. Keyt
  38. J. Biol. Chem. v.271 The carboxylterminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency Keyt, B. A.;L. T. Berleau;H. V. Nguyen;H. V. Nguyen;H. Chen;H. Heinsohn;R. Vandlen;N. Ferrara
  39. J. Immunol. v.152 Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis Koch, A.E.;L.A. Harlow;G. K. Haines;E. P. Amento;E. N. Unemori;W. L. Wong;R. M. Pope;N. Ferrara
  40. Science v.246 Vascular endothelial growth factor is a secreted angiogenic mitogen Leung, D. W.;G. Cachianes;W. J. Kuang;D. V. Goeddel;N. Ferrara
  41. J. Biol. Chem. v.275 Receptor-selective variants of human VEGF: Generation and characterization Li, B.;G. Fuh;G. Meng;X. Xin;M. E. Gerritsen;B. Cunningham;A. M. de Vos
  42. E. coli. Curr. Opin. Biotechnol. v.9 Advances in refolding of proteins produced Lilie, H.;E. Schwarz;R. Rudolph
  43. Biotechnol. Prog. v.13 Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme Maachupalli-Reddy, J.;B. D. Kelley;E. De Bernardez Clark
  44. Proc. Natl. Acad. Sci. USA v.88 Isolation of a human placenta cDNA coding for aprotein related to the vascular permeability factor Maglione, D.;V. Guerriero;G. Viglietto;M. Ferraro;O. Aprelikova;K. Alitalo;S. Vecchio;K. Lei;J. Chou;M. Persico
  45. Oncogene v.8 Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome Maglione, D.;V. Guerriero;G. Viglietto;M.G. Ferraro;O. Aprelikova;K. Alitalo;S. Del Vecchic;K. J. Lei;J. Y. Chou;M. G. Persico
  46. J. Biol. Chem. v.274 Differential binding of vascular endothelial growth factor Bsplice and proteolytic isoforms to neuropilin-1 Makinen, T.;B. Olofsson;T. Karpanen;U. Hellman;S. Soker;M. Klagsbroun;U. Eriksson;K. Alitalo
  47. EMBO J. v.18 A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E mediates angiogenesis via signalling through VEGFR-s (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases Mayer, M.;M. Clauss;A. Lepple-Wienhues;J. Waltenberger;H.G. Augustin;M. Ziche;C. Lanz;M. Buttner;H.-J. Rziha;C. Dehio
  48. Structure v.5 The crystal structure of vascular endothelial growth factor(VEGF) refined to 1.193 ${\AA}$ resolution:Multiple copy flexibility and receptor binding Muller, Y.A.;H. W. Christinger;B.A. Keyt;A. M. de Vos.
  49. Proc. Natl. Acad. Sci. USA v.94 Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site Muller, Y.A.;B. Li;H. W. Christinger;J. A. Wells;B. C. Cunningham;A. M. de Vos
  50. J. Cell Biol. v.129 Endothelial receptor tyrosine kinases involved in angiogenesis Mustonen, T.;K. Alitalo
  51. J. Biol. Chem v.273 A novel type of vascular endothelial growth factor, VEGF-E(NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain Ogawa, S.;A. Oku;A. Sawano;S. Yamaguchi;Y. Yazaki;M. Shibuya
  52. Proc. Natl. Acad. Sci. USA v.95 Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells Olofsson, B.;E. Korpelainen;M. S. Pepper;S. J. Mandriota;K. Aase;V. Kumar;Y. Gunji;M.M. Jeltsch;M. Shibuya;K. Alitalo;U. Eriksson
  53. Proc. Natl. Acad. Sci. USA v.93 Vascular endothelial grpwth factor B, a novel growth factor for endothelial cells Olofsson, B.;K. Pajusola;A. Kaipainen;G. von Euler;V. Joukov;O. Saksela;A. Orpana;R. Pettersson;K. Alitalo;U. Eriksson
  54. Proc. Natl. Acad. Sci. USA v.93 Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family Orlandini, M.'L. Marconcini;R. Ferruzzi;S. Oliviero
  55. Nature v.407 Crystal structure of fibroblast growth factor receptor ecotodomain bound to ligand and heparin Pellegrini, L.;D.F. Burke;F. von Delft;B. Mulloy;T.L. Blundell
  56. Herz v.25 The VEGF splice variants: Properties, receptors, and usage for the treatment of ischemic diseases Poltorak, Z.;T. Cohen;G. Neufeld
  57. J. Biol. Chem. v.272 VEGF145, a sereted vascular endothelial growth factor isoform that binds to extracellular matrix Poltorak, Z.;T. Cohen;R. Sivan;Y. Kandelis;G. Spira;I. Vlodavsky;E. Keshet;G. Neufeld
  58. J. Biol. Chem. v.275 Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells Rahimi, N.;V. Dayanir;K. Lashkari
  59. Am. J. Physiol. Renal. Physiol. v.279 Coexpression of neuropilin-1 Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli Robert, B.;X. Zhao;D. R. Abrahamson
  60. Modern Methods in Protein and Nucleic Acid Research Renaturation of recombinant, disulfidebonded proteins from inclusion bodies Rudopoh, R.;Tschesche,H.(ed.)
  61. FASEB v.10 In vitro folding of inclusion body proteins Rudolph, R.;H. Lilie
  62. Cell Growth Differ v.7 Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor Sawano, A.;T. Takahashi;S. Yamaguchi;M. Aonuma;M. Shibuya
  63. Protein Sci v.9 Purification and refolding of vascular endothelial growth factor-B Scrofani, S.D.B.;L. J. Fabri;R. Xu;P. Maccarone;A. D. Nash
  64. Oncogene v.5 Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene(flt) closely related to the fms family Shibuya, M.;S. Yamaguchi;A. Yamane;T. Ikeda;A. Tojo;H. Matsushime;M. Sato
  65. Escherichia coli Biochem. Biophys. Res. Commun v.222 Expression of biologically active isoforms of the tumor angiogenesis factor VEGF Siemeister, G.;B. Schnurr;K. Mohrs;C. Schachtele;D. Marme;G. Martiny-Baron
  66. J. Biol. Chem. v.274 Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimaers Stacker, S. A.;K. Stenvers;C. Caesar;A. Vitali;T. Domagala;E. Nice;S. Roufail;R.J. Simpson;R. Moritz;T. Karpanen;K. Allitalo;M.G. Achen
  67. J. Biol. Chem. v.274 A mutant form of vascular endothelial growth factor(VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability Stacker, S.A.;A. Vitali;C. Caesar;T. Domagala;L. C. Groenen;E. Nice;M. G. Achen;A. F. Wilks
  68. J. Biol. Chem. v.273 A novel alternatively spliced form of murine vascular endothelial growth factor, VEGF 115 Sugihara, T.;R. Wadhwa;S. C. Kaul;Y. Mitsui
  69. Oncogene v.6 Identification of a new endothelial cell growth factor receptor tyrosine kinase Terman, B. I.;M. E. Carrion;E. Kovacs;B. A. Rasmussen;R. L. Eddy;T. B. Shows
  70. Biochem. Biophys. Res. Commun. v.187 Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor Terman, B.I.;M. Dougher-Vermazen;M. E. Carrion;D. Dimitrov;D.C. Armellino;D. Gospodarowicz;P. Bohlen
  71. Appl. Biochem. Biotechnol. v.66 Molecular chaperones, folding catalysts,and the recovery of active recombinant proteins from E. coli To fold or to refold Thomas, J. G.;A. Ayling;F. Baneyx
  72. J. Biol. Chem. v.266 The human gene for vascular endothelial growth factor. Multiple protein forms anr encoded through alternative exon splicing Tischer, E.;R. Mitchell;T. Hartman;M. Silva;D. Gospodarowicz;J.C. Fiddes;J.A. Abraham
  73. Annu. Rev. Cell Biol. v.10 Receptor protein-tyrosine kinases and their signal transduction pathways Van der Greer, P.;T. Hunter;R. A. Lindberg
  74. Lab. Invest. v.744 The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation Walter, D. H.;U. Hink;T. Asahara;E. Van Belle;J. Horowitz;Y. Tsurumi;R. Vandlen;H. Heinsohn;B. Keyt;N. Ferrara;J. F. Symes;J. M. Isner
  75. Circ. Res. v.83 Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1 Wang, H.;J. A. Keiser
  76. Protein Eng v.2 The oxidative folding of proteins vy disulfide plus thiol does not correlate with redox potential Wetlaufer, D. B.;P.A. Branca;G.X. Chen
  77. Biochemistry v.37 Crystal structure of the complex between VEGF and a receptor-blocking peptide Wiesmann, C.;H. W. Christinger;A. G. Cochran;B. C. Cunningham;W. J. Fairbrother;C.J. Keenean;G. Meng;A.M. de Vos
  78. Cell v.91 Crystal structure at 1.7 ${\AA}$ resolution of VEGF in complex with domain 2 of the Flt-1 receptor Wiesmann, C.;G. Fuh;H. W. Christinger;C. Eigenbrot;J.A. Wells;A. M. deVos
  79. Proc. Natl. Acad. Sci. USA v.96 Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1 Wise, L. M.;T. veikkola;A.A. Mercer;L. J. Savory;S. B. Fleming;C. Caesar;A. Vitali;T. Makinen;K. Alitalo;S. A. Stacker